• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4+CD25+调节性T细胞降低了肺癌患者细胞因子诱导的杀伤(CIK)细胞的抗肿瘤活性。

CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.

作者信息

Li Hui, Yu Jin-Pu, Cao Shui, Wei Feng, Zhang Peng, An Xiu-Mei, Huang Zong-Tang, Ren Xiu-Bao

机构信息

Department of Immunology, Cancer Institute and Hospital, Tianjin Medical University, Tianjin, 30060, China,

出版信息

J Clin Immunol. 2007 May;27(3):317-26. doi: 10.1007/s10875-007-9076-0. Epub 2007 Apr 28.

DOI:10.1007/s10875-007-9076-0
PMID:17468835
Abstract

: CD(4) (+)CD(25) (+) regulatory T cells (Tregs) have been shown to inhibit cytotoxic lymphocytes-mediated immune responses. Cytokine-induced killer (CIK) cells exert high impact on adoptive immunotherapeutic approaches. Therefore, the purpose of this report was to determine the effect of Tregs on CIK cell growth and CIK-induced cytotoxicity for inhibition of tumor growth in vivo as well as in vitro. After depletion of CD(4) (+)CD(25) (+) cells before culture, the proliferation and cytotoxicity of CIK cells, which indicated in bromodeoxyuridine (BrdU) and lactic dehydrogenase (LDH) assays, were significantly increased. Depletion of CD(4) (+)CD(25) (+) cells preculture also enhanced the suppression effect on the lung cancer cells inoculated in experimental animals. Blockage of glucocorticoid-induced tumor necrosis factor receptor (GITR) and transforming growth factor beta1 (TGF-beta1) by antibodies partially abrogated the suppressive effect of CD(4) (+)CD(25) (+) cells on CIK. These results indicated that Tregs could inhibit the antitumor activity of CIK cells. The molecules TGF-beta and GITR may contribute to the suppressive function of CD(4) (+)CD(25) (+) cells.

摘要

CD4(+)CD25(+)调节性T细胞(Tregs)已被证明可抑制细胞毒性淋巴细胞介导的免疫反应。细胞因子诱导的杀伤(CIK)细胞对过继性免疫治疗方法有很大影响。因此,本报告的目的是确定Tregs对CIK细胞生长和CIK诱导的细胞毒性的影响,以抑制体内和体外肿瘤生长。在培养前去除CD4(+)CD25(+)细胞后,CIK细胞的增殖和细胞毒性(通过溴脱氧尿苷(BrdU)和乳酸脱氢酶(LDH)测定表明)显著增加。预培养时去除CD4(+)CD25(+)细胞也增强了对接种于实验动物的肺癌细胞的抑制作用。用抗体阻断糖皮质激素诱导的肿瘤坏死因子受体(GITR)和转化生长因子β1(TGF-β1)可部分消除CD4(+)CD25(+)细胞对CIK的抑制作用。这些结果表明,Tregs可抑制CIK细胞的抗肿瘤活性。TGF-β和GITR分子可能有助于CD4(+)CD25(+)细胞的抑制功能。

相似文献

1
CD4 +CD25 + regulatory T cells decreased the antitumor activity of cytokine-induced killer (CIK) cells of lung cancer patients.CD4+CD25+调节性T细胞降低了肺癌患者细胞因子诱导的杀伤(CIK)细胞的抗肿瘤活性。
J Clin Immunol. 2007 May;27(3):317-26. doi: 10.1007/s10875-007-9076-0. Epub 2007 Apr 28.
2
Cord blood CD4/CD25 T cells down-regulates NKG2D on cytokine-induced killer cells.脐带血 CD4+/CD25+ T 细胞下调细胞因子诱导的杀伤细胞上的 NKG2D。
Front Biosci (Landmark Ed). 2019 Jun 1;24(7):1259-1270. doi: 10.2741/4778.
3
[Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].[树突状细胞减少细胞因子诱导的杀伤细胞中CD4 + CD25 +细胞的数量和功能]
Zhonghua Yi Xue Za Zhi. 2005 Nov 23;85(44):3134-8.
4
Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4CD25 regulatory T cells.吉西他滨治疗通过消耗CD4CD25调节性T细胞增强了细胞因子诱导的杀伤细胞的抗肿瘤作用。
Immunol Lett. 2017 Jan;181:36-44. doi: 10.1016/j.imlet.2016.11.009. Epub 2016 Nov 17.
5
Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.抗血管生成治疗联合过继细胞免疫治疗在非小细胞肺癌模型中具有更好的抗肿瘤效果。
PLoS One. 2013 Jun 14;8(6):e65757. doi: 10.1371/journal.pone.0065757. Print 2013.
6
Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells.白花蛇舌草多糖增强细胞因子诱导的杀伤细胞的抗肿瘤活性。
Biomed Pharmacother. 2019 Sep;117:109167. doi: 10.1016/j.biopha.2019.109167. Epub 2019 Jul 6.
7
[Antitumor effects of cocultured dendritic cells and cytokine-induced killer cells on lung cancer in vitro and in vivo].共培养树突状细胞和细胞因子诱导的杀伤细胞对肺癌的体内外抗肿瘤作用
Ai Zheng. 2006 Nov;25(11):1329-33.
8
[Coculture of dendritic cell with cytokine-induced killer results in a significant increase in cytotoxic activity of CIK to tumor cells in vitro and in vivo].树突状细胞与细胞因子诱导的杀伤细胞共培养导致细胞因子诱导的杀伤细胞在体外和体内对肿瘤细胞的细胞毒性活性显著增加。
Zhonghua Xue Ye Xue Za Zhi. 2004 May;25(5):277-80.
9
[The anti-tumor effects of dendritic cells co-cultured with cytokine induced killer cells after chemotherapy].化疗后细胞因子诱导的杀伤细胞与树突状细胞共培养的抗肿瘤作用
Zhonghua Jie He He Hu Xi Za Zhi. 2004 May;27(5):315-9.
10
Enhanced killing of primary ovarian cancer by retargeting autologous cytokine-induced killer cells with bispecific antibodies: a preclinical study.通过双特异性抗体重新靶向自体细胞因子诱导的杀伤细胞增强原发性卵巢癌的杀伤作用:一项临床前研究。
Clin Cancer Res. 2006 Mar 15;12(6):1859-67. doi: 10.1158/1078-0432.CCR-05-2019.

引用本文的文献

1
The distribution characteristics of PD-1 pathway-related immune cells in esophageal cancer tissue and their prognostic significance.食管癌组织中PD-1通路相关免疫细胞的分布特征及其预后意义。
PLoS One. 2025 Jun 30;20(6):e0325349. doi: 10.1371/journal.pone.0325349. eCollection 2025.
2
Revising the Landscape of Cytokine-Induced Killer Cell Therapy in Lung Cancer: Focus on Immune Checkpoint Inhibitors.修订肺癌细胞因子诱导的杀伤细胞治疗领域:聚焦免疫检查点抑制剂。
Int J Mol Sci. 2023 Mar 15;24(6):5626. doi: 10.3390/ijms24065626.
3
CD4 T cells are required to improve the efficacy of CIK therapy in non-small cell lung cancer.

本文引用的文献

1
IL-2 immunotoxin therapy modulates tumor-associated regulatory T cells and leads to lasting immune-mediated rejection of breast cancers in neu-transgenic mice.白细胞介素-2免疫毒素疗法可调节肿瘤相关调节性T细胞,并导致神经转基因小鼠对乳腺癌产生持久的免疫介导排斥反应。
J Immunol. 2006 Jul 1;177(1):84-91. doi: 10.4049/jimmunol.177.1.84.
2
Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines.肿瘤的化学免疫疗法:环磷酰胺与基于外泌体的疫苗协同作用。
J Immunol. 2006 Mar 1;176(5):2722-9. doi: 10.4049/jimmunol.176.5.2722.
3
Th1 bias in PBMC induced by multicycles of auto-CIKs infusion in malignant solid tumor patients.
CD4 T 细胞对于提高非小细胞肺癌 CIK 治疗的疗效是必需的。
Cell Death Dis. 2022 May 6;13(5):441. doi: 10.1038/s41419-022-04882-x.
4
Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine.免疫检查点阻断增强治疗性肺癌疫苗的免疫活性。
Vaccines (Basel). 2020 Nov 5;8(4):655. doi: 10.3390/vaccines8040655.
5
Clinical efficacy of intra-cavitary infusions of autologous dendritic cell/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and ascites.腔内输注自体树突状细胞/细胞因子诱导的杀伤细胞制品治疗难治性恶性胸腔积液和腹水的临床疗效
Am J Transl Res. 2020 Jul 15;12(7):3940-3952. eCollection 2020.
6
CIK cell cytotoxicity is a predictive biomarker for CIK cell immunotherapy in postoperative patients with hepatocellular carcinoma.CIK 细胞细胞毒性是预测肝癌术后患者 CIK 细胞免疫治疗的生物标志物。
Cancer Immunol Immunother. 2020 May;69(5):825-834. doi: 10.1007/s00262-020-02486-y. Epub 2020 Feb 14.
7
Radiotherapy combined with cytokine-induced killer cell therapy for liver metastasis from rectal cancer: A case report.放疗联合细胞因子诱导的杀伤细胞疗法治疗直肠癌肝转移:一例报告
Medicine (Baltimore). 2019 Oct;98(43):e17636. doi: 10.1097/MD.0000000000017636.
8
Interleukin-35 as an Emerging Player in Tumor Microenvironment.白细胞介素-35作为肿瘤微环境中的新兴因子
J Cancer. 2019 May 12;10(9):2074-2082. doi: 10.7150/jca.29170. eCollection 2019.
9
Primitive neuroectodermal tumor of the kidney at the advanced stage: A case series of eight Chinese patients.晚期肾原始神经外胚层肿瘤:8例中国患者的病例系列
Mol Clin Oncol. 2018 Jun;8(6):743-748. doi: 10.3892/mco.2018.1611. Epub 2018 Apr 19.
10
Analytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.患者来源的细胞因子诱导的杀伤细胞的分析和动态分泌谱。
Mol Med. 2017 Oct;23:235-246. doi: 10.2119/molmed.2017.00084. Epub 2017 Aug 9.
恶性实体瘤患者多次自体CIK细胞输注诱导外周血单个核细胞出现Th1偏移
Cancer Biother Radiopharm. 2006 Feb;21(1):22-33. doi: 10.1089/cbr.2006.21.22.
4
The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.CD4+CD25+调节性T细胞对肿瘤特异性CD8+T细胞细胞毒性及癌症的影响。
Semin Cancer Biol. 2006 Apr;16(2):124-36. doi: 10.1016/j.semcancer.2005.11.006. Epub 2006 Jan 26.
5
CD25+ regulatory T cell depletion augments immunotherapy of micrometastases by an IL-21-secreting cellular vaccine.CD25 + 调节性T细胞耗竭通过分泌白细胞介素-21的细胞疫苗增强微转移的免疫治疗。
J Immunol. 2006 Feb 1;176(3):1750-8. doi: 10.4049/jimmunol.176.3.1750.
6
CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.CD4+CD25+ 调节性T细胞抑制自然杀伤细胞介导的癌症免疫治疗。
J Immunol. 2006 Feb 1;176(3):1582-7. doi: 10.4049/jimmunol.176.3.1582.
7
CIK cells from patients with HCC possess strong cytotoxicity to multidrug-resistant cell line Bel-7402/R.肝癌患者的CIK细胞对多药耐药细胞系Bel-7402/R具有强大的细胞毒性。
World J Gastroenterol. 2005 Jun 14;11(22):3339-45. doi: 10.3748/wjg.v11.i22.3339.
8
TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells.转化生长因子β1维持CD4+CD25+调节性T细胞的抑制功能和叉头框蛋白3表达。
J Exp Med. 2005 Apr 4;201(7):1061-7. doi: 10.1084/jem.20042276.
9
A phase I trial of autologous cytokine-induced killer cells for the treatment of relapsed Hodgkin disease and non-Hodgkin lymphoma.一项关于自体细胞因子诱导杀伤细胞治疗复发霍奇金病和非霍奇金淋巴瘤的I期试验。
Biol Blood Marrow Transplant. 2005 Mar;11(3):181-7. doi: 10.1016/j.bbmt.2004.11.019.
10
CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.CD4 +辅助性T细胞增强了CD8 + T细胞对肿瘤/自身抗原的免疫反应,而天然存在的调节性T细胞则对其产生阻碍。
J Immunol. 2005 Mar 1;174(5):2591-601. doi: 10.4049/jimmunol.174.5.2591.